PI Industries Limited
2,076.00
INR
-35.00
(-1.66%)
ISIN
INE603J01030
Return %
Stock
S&P 500
1Y
-41.18
14.20
3Y
-40.02
81.12
5Y
-31.54
68.34
Capital Structure
INR
•
in mil. unless spec.Working Capital
INR
•
in mil. unless spec.Growth Rates
INR
•
in mil. unless spec.Quarterly Revenue
INR
•
in mil. unless spec.Quarterly Earnings Per Share
INR
•
in mil. unless spec.Quarterly Dividends Per Share
INR
•
in mil. unless spec.Company Description
- CEO
- Mayank Singhal
- Full Time Employees
- 6,353
- Sector
- Process industries
- Industry
- Chemicals: specialty
- Address
- Vipul Square Gurgaon HA India 122009
- IPO Date
- Jun 14, 2011
- Website
- piindustries.com
- Similar Companies
- Business
- PI Industries Limited operates as an integrated agrisciences enterprise, engaged in the development, manufacturing, and distribution of diverse chemical solutions across India, other parts of Asia, North America, and Europe, serving international markets. The company’s primary focus includes a comprehensive range of crop protection products such as insecticides, fungicides, and herbicides, alongside specialty plant nutrient offerings and biostimulants. Notable brands within their agrochemical portfolio encompass Osheen, Biovita, Nominee Gold, and Humesol. Beyond its branded agricultural inputs, PI Industries is a prominent provider of Custom Synthesis and Manufacturing (CSM) solutions. This segment offers extensive services, from process research and development to analytical method validation, scale-up studies, and commercial-scale production of advanced intermediates and specialized fine chemicals for global innovators. The company is recognized for its strong emphasis on intellectual property protection and a non-compete business model, fostering partnerships with leading international firms. In a strategic expansion, PI Industries has diversified into the pharmaceutical contract development and manufacturing organization (CDMO) sector through its subsidiary, PI Health Sciences Limited. This move, supported by acquisitions including Therachem Research Medilab and Archimica S.p.A., enables the company to provide contract research, CDMO, and active pharmaceutical ingredient (API) solutions, leveraging its expertise in complex chemistry for medicinal chemistry and drug discovery across regulated markets in India, the US, and Europe. The company also maintains robust research and development capabilities, driving innovation from target identification and molecule design to biological evaluation and synthetic route development. PI Industries continually enhances its operational footprint with multiple manufacturing facilities across India and is actively integrating new technologies like drones in agricultural applications while pursuing partnerships in biocontrol technologies. The distribution of its products occurs through an extensive network of distributors, dealers, and retailers. Originally incorporated in 1946 as Mewar Oil & General Mills Ltd., PI Industries Limited is headquartered in Gurugram, India.